BSE filing, BSE: 543207. Summary written from the filing by ALFA Finder's alert engine.
Natural Biocon (India) Ltd: key numbers
- Share price
- ₹1.71
- Market cap
- ₹4.41 Cr
- Revenue (annual)
- ₹2.54 Cr
- Net profit (annual)
- ₹-0.04 Cr
- P/E (TTM)
- -23.2×Sector 34.1×
- Promoter holding
- 9.36%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Natural Biocon (India) Ltd
All →Natural Biocon (India) Other Announcement
Natural Biocon (India) Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, as per SEBI regulations.
Natural Biocon (India) Management Change
Ms. Shruti Sharma has resigned as Company Secretary and Compliance Officer of Natural Biocon (India) Ltd, effective from 26th September 2026.
Natural Biocon (India) Board Meeting Outcome
Natural Biocon approved the Director's report and scheduled its 34th Annual General Meeting for September 30, 2026. It also announced leadership changes, including new director appointments.
Natural Biocon (India) Board Meeting Date
Natural Biocon (India) Ltd will hold a board meeting on September 5, 2026, to consider AGM matters and approve various annual reports.
Natural Biocon (India) Q1 FY27 Results: Net Profit ₹0 Cr
Natural Biocon (India) Ltd reported net profit of ₹0 Cr for Q1 FY27.
- Key figure
- Net profit ₹0 Cr
Natural Biocon (India) Board Meeting Date
Natural Biocon (India) Ltd will hold a board meeting on August 14, 2026. The agenda includes approving quarterly results and appointing new statutory auditors.
Other other announcement announcements
All →Mahindra & Mahindra Financial Services Other Announcement
Mahindra & Mahindra Financial filed its ALM statement as of September 30, 2026, submitted to RBI. It is a periodic regulatory return with no new transaction.
ACME Solar Holdings Other Announcement
ACME Solar filed the CARE Ratings monitoring agency report on its Rs.2,800 crore QIP for the quarter ended 30 September 2026. The report shows no deviation from the offer objects.
eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.